Constitution Statuten
Content Author Instructions
Winterworkshop 2008 Winterworkshop 2007 Winterworkshop 2006 Winterworkshop 2005 Winterworkshop 2004 Awards
Instructions to Authors

General. It is the policy of Pteridines to publish reviews, original papers, short communications, technical notes, letters to the editors and reports of meetings dealing with all aspects of the chemistry, pathobiochemistry, clinical biochemistry, clinical toxicology, drug monitoring and laboratory diagnosis of genetic disorders, both in humans and in animals of pteridines and related materials. Papers are published after refereeing. Contributions appear in English only: they are accepted on the understanding that the work described has not been published before (except in the form of an abstract or as part of a published lecture review or thesis), that it is not under consideration for publication elsewhere, that its publication has been approved by all the authors and by the responsible authorities - tacitly or explicitly - in the laboratories where the work was carried out and that, if accepted, it will not be published elsewhere in the same form, in either the same or another language, without the consent of the copyright holders. Reference should be made to previously, published abstracts, etc. in the introduction.
The complete manuscript including tables and figures should be send via e-mail to:

Dr.Dietmar Fuchs
Division of Biological Chemistry, Biocentre
Innsbruck Medical University 
Innrain 80
A-6020 Innsbruck, Austria
dietmar.fuchs@i-med.ac.at

Preparation of manuscripts
Manuscripts should be typewritten with double spacing. They should be written so as to be clear and concise. As a guide the following format should be used. Spelling should be according to the Concise Oxford Dictionary of Current English or to Webster's New World Dictionary of the American Language.
Title page. The first page should contain (in normal type, not in capital letters): a concise title; the complete name(s) of the author(s) the name of the laboratory where the work was carried out; the address to which correspondence (including proofs) should be sent; the full postal address(es) of (all) the author(s) in the language of the country of origin (in Latin transliteration); a running title (maximum 70 letters incl. spaces); a dedication (if any); any of the following footnotes: a) funding organisation(s), b) enzymes; all enzyme (not to be abbreviated!) mentioned in the text should be listed in alphabetical order of their recommended trivial names, followed by their systematic names and Enzyme Commission (EC) numbers in parentheses. 
Summary: Every paper except short communications must be preceded by a summary containing project, results and conclusions (concise, in abstract form).
Introduction: This should define the problem and, if possible, the frame of existing knowledge. Please ensure that people not working in your particular field will be able to understand your intentions. 
Materials and Methods: General methods, equipment and purchased material should be mentioned. Description of the experiments should be as precise as possible to enable other scientists to repeat your work. New compounds have to be characterized by elemental analysis, melting point and physical data taken from UV, IR and NMR spectra.
Results: Only material pertinent to the subject must be included. Data must not be repeated in figures and tables.
Discussion: This part should interpret the results in view of the problem as outlined in the introduction and of related observations by yourself or others. Implications for further studies or applications may be discussed. A conclusion should be added if results and discussion are combined.
Acknowledgments: Acknowledgments should be given at the end of the text. The names of the funding organizations should be written in full.
References: Bibliographic citations should appear in numeral order in brackets and in order of their citation in the text. Reference to unpublished work should be kept to a minimum and, mentioned in the text itself in parentheses. All authors should be listed when there are six and fewer; when there are seven or more, list only the first three and add "et al". References will follow the Vancouver style described in the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" with the exception that pagination should be complete. The following are sample styles:

Journal references:
1. Platterson EL, Saltza MH, Stockstad ELR. The isolation and characterization of a pteridine required for the growth of Chrithidia fasciculata. J Am Chem Soc 1956; 78: 5871-5873.
Book reference:
2. Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss G, Werner ER, Werner Felmayer G. Neopterin; biochemistry methods, clinical application. Berlin-New York: Walter deGruyter 1992.
Book chapter reference:
3. Pfleiderer W, Kang Y, Soyka R, Hutzenlaub W, Wiesenfeldt M, Leskopf W. Side-chain chemistry of pteridines. In: Cooper BA, Whitehead VM, eds. Chemistry and biology of pteridines and folic acid derivatives. Berlin-New York: Walter deGruyter 1986; 31-44.

Figures. Each figure must be submitted on a single sheet. The figures should be numbered consecutively in Arabic numerals. Legends should be concise and self-explanatory and must be typed on a separate page. Figures are to submitted in an electronic format, preferably as jpg-file and a power-point original drawing. Note, that the published work will directly reflect the quality of the artwork provided. All figures must be mentioned in the text. Figures will be reduced as far as possible, preferably either to the width of one column (80 mm, 3 inches) or two columns (165 mm, 6.5 inches).

Tables. Tables must be preceded by a concise and self-explanatory heading and numbered in Arabic numerals. Each table must be presented on a single sheet. All tables must be mentioned in the text.

Units. SI units should be used except in some few cased where non-SI units are more common. 

Nomenclature. The journal will follow the nomenclature rule of IUPAC and of the IUPAB-IUB Commission on Biochemical Nomenclature, the recommendations of this commission for abbreviations and symbols, and the recommendations of the International Federation of Clinical Chemistry. Abbreviations not recommended by IUPAC, IUB and IFCC commissions should be kept to a minimum and should be listed on a separate page. For specific nomenclature recommendation of pteridines, see www.pteridines.org.

PDF-file: Pdf-file is supplied free of charge to the corresponding author of a published article.

Copyright. In accepting the manuscript, the publishers acquire the copyright and the exclusive right for reproduction, distribution and translation. The publishers reserve the right to publish the contents of this Journal in other languages. Duplication and reproduction (including photo- and micro-copying) of articles and figures is only possible with the written permission of the publishers. According to copyright law, it is permissible to make a few copies of individual articles for personal use only.